Conditioned media downregulates nuclear expression of Nrf2

Cellular and Molecular Bioengineering

Volumn 6, Issue 2, 2013, Pages 130-137

  Sarkar, Saheli ^a   Payne, Christine K ^a   Kemp, Melissa L ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Cell synchronization; Conditioned media; Keap1; Nrf2; Serum free media; Starvation

Indexed keywords

KELCH LIKE ECH ASSOCIATED PROTEIN 1; TRANSCRIPTION FACTOR NRF2;

ARTICLE; AUTOREGULATION; CELL CULTURE; CELL FRACTIONATION; CELL SYNCHRONIZATION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOLYSIS; DOSE RESPONSE; DOWN REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

EID: 84879506755     PISSN: 18655025     EISSN: 18655033     Source Type: Journal    
DOI: 10.1007/s12195-013-0272-0     Document Type: Article

References (47)

1. Braun, S., C. Hanselmann, M. G. Gassmann, U. Auf Dem Keller, C. Born-Berclaz, K. Chan, Y. W. Kan, and S. Werner. Nrf2 transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound. Mol. Cell. Biol. 22:5492-5505, 2002.
2. Chen, Y., M. B. Azad, and S. B. Gibson. Superoxide is the major reactive oxygen species regulating autophagy. Cell Death Differ. 16:1040-1052, 2009.
3. 2 and inflammatory cytokine production. PLoS ONE 3:e3367, 2008.
4. Correa, F., E. Ljunggren, C. Mallard, M. Nilsson, S. G. Weber, and M. Sandberg. The Nrf2-inducible antioxidant defense in astrocytes can be both up- and down-regulated by activated microglia: involvement of p38 MAPK. Glia 59:785-799, 2011.
5. Cullinan, S. B., and J. A. Diehl. PERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress. J. Biol. Chem. 279:20108-20117, 2004.
6. Damiano, F., S. Alemanno, G. V. Gnoni, and L. Siculella. Translational control of the sterol-regulatory transcription factor SREBP-1 mRNA in response to serum starvation or ER stress is mediated by an internal ribosome entry site. Biochem. J. 429:603-612, 2010.
7. Denicola, G. M., F. A. Karreth, T. J. Humpton, A. Gopinathan, C. Wei, K. Frese, D. Mangal, K. H. Yu, C. J. Yeo, E. S. Calhoun, F. Scrimieri, J. M. Winter, R. H. Hruban, C. Iacobuzio-Donahue, S. E. Kern, I. A. Blair, and D. A. Tuveson. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 475:106-109, 2011.
8. Eichelbaum, K., M. Winter, M. B. Diaz, S. Herzig, and J. Krijgsveld. Selective enrichment of newly synthesized proteins for quantitative secretome analysis. Nat. Biotechnol. 30:984-990, 2012.
9. Gunawardana, C. G., C. Kuk, C. R. Smith, I. Batruch, A. Soosaipillai, and E. P. Diamandis. Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer. J. Proteome Res. 8:4705-4713, 2009.
10. Hayes, J. D., and M. Mcmahon. Nrf2 and Keap1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem. Sci. 34:176-188, 2009.
11. Homma, S., Y. Ishii, Y. Morishima, T. Yamadori, Y. Matsuno, N. Haraguchi, N. Kikuchi, H. Satoh, T. Sakamoto, N. Hizawa, K. Itoh, and M. Yamamoto. Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer. Clin. Cancer Res. 15:3423-3432, 2009.
12. Innamorato, N. G., A. I. Rojo, A. J. Garcia-Yague, M. Yamamoto, M. L. De Ceballos, and A. Cuadrado. The transcription factor Nrf2 is a therapeutic target against brain inflammation. J. Immunol. 181:680-689, 2008.
13. Kang, K. W., S. J. Lee, J. W. Park, and S. G. Kim. Phosphatidylinositol 3-kinase regulates nuclear translocation of NF-E2-related factor 2 through actin rearrangement in response to oxidative stress. Mol. Pharmacol. 62:1001-1010, 2002.
14. Kaspar, J. W., S. K. Niture, and A. K. Jaiswal. Nrf2:INrf2 (keap1) signaling in oxidative stress. Free Radic. Biol. Med. 47:1304-1309, 2009.
15. Kensler, T. W., N. Wakabayashi, and S. Biswal. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 47:89-116, 2007.
16. Kim, J., Y. S. Choi, S. Lim, K. Yea, J. H. Yoon, D. J. Jun, S. H. Ha, J. W. Kim, J. H. Kim, P. G. Suh, S. H. Ryu, and T. G. Lee. Comparative analysis of the secretory proteome of human adipose stromal vascular fraction cells during adipogenesis. Proteomics 10:394-405, 2010.
17. Kobayashi, A., M. I. Kang, Y. Watai, K. I. Tong, T. Shibata, K. Uchida, and M. Yamamoto. Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol. Cell. Biol. 26:221-229, 2006.
18. Koh, K., Y. Cha, S. Kim, and J. Kim. TBHQ inhibits LPS-induced microglial activation via Nrf2-mediated suppression of p38 phosphorylation. Biochem. Biophys. Res. Commun. 380:449-453, 2009.
19. Kulasingam, V., and E. P. Diamandis. Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets. Mol. Cell. Proteomics 6:1997-2011, 2007.
20. Larsson, O., A. Zetterberg, and W. Engstrom. Cell-cycle-specific induction of quiescence achieved by limited inhibition of protein synthesis: counteractive effect of addition of purified growth factors. J. Cell Sci. 73:375-387, 1985.
21. Levin, V. A., S. C. Panchabhai, L. Shen, S. M. Kornblau, Y. Qiu, and K. A. Baggerly. Different changes in protein and phosphoprotein levels result from serum starvation of high-grade glioma and adenocarcinoma cell lines. J. Proteome Res. 9:179-191, 2010.
22. Liu, X. M., K. J. Peyton, D. Ensenat, H. Wang, M. Hannink, J. Alam, and W. Durante. Nitric oxide stimulates heme oxygenase-1 gene transcription via the Nrf2/ARE complex to promote vascular smooth muscle cell survival. Cardiovasc. Res. 75:381-389, 2007.
23. Martin, D., A. I. Rojo, M. Salinas, R. Diaz, G. Gallardo, J. Alam, C. M. De Galarreta, and A. Cuadrado. Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol. J. Biol. Chem. 279:8919-8929, 2004.
24. Min, K. J., M. S. Yang, S. U. Kim, I. Jou, and E. H. Joe. Astrocytes induce heme oxygenase-1 expression in microglia: a feasible mechanism for preventing excessive brain inflammation. J. Neurosci. 26:1880-1887, 2006.
25. Moi, P., K. Chan, I. Asunis, A. Cao, and Y. W. Kan. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc. Natl. Acad. Sci. U.S.A. 91:9926-9930, 1994.
26. Nguyen, T., P. J. Sherratt, H. C. Huang, C. S. Yang, and C. B. Pickett. Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome. J. Biol. Chem. 278:4536-4541, 2003.
27. Nguyen, T., P. J. Sherratt, P. Nioi, C. S. Yang, and C. B. Pickett. Nrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleocytoplasmic shuttling by Keap1. J. Biol. Chem. 280:32485-32492, 2005.
28. Pirkmajer, S., and A. V. Chibalin. Serum starvation: caveat emptor. Am. J. Physiol. Cell Physiol. 301:C272-C279, 2011.
29. Pocsfalvi, G., G. Votta, A. De Vincenzo, I. Fiume, D. A. Raj, G. Marra, M. P. Stoppelli, and I. Iaccarino. Analysis of secretome changes uncovers an autocrine/paracrine component in the modulation of cell proliferation and motility by c-Myc. J. Proteome Res. 10:5326-5337, 2011.
30. Purdom-Dickinson, S. E., E. V. Sheveleva, H. Sun, and Q. M. Chen. Translational control of Nrf2 protein in activation of antioxidant response by oxidants. Mol. Pharmacol. 72:1074-1081, 2007.
31. Reddy, N. M., S. R. Kleeberger, J. H. Bream, P. G. Fallon, T. W. Kensler, M. Yamamoto, and S. P. Reddy. Genetic disruption of the Nrf2 compromises cell-cycle progression by impairing GSH-induced redox signaling. Oncogene 27:5821-5832, 2008.
32. Ren, D., N. F. Villeneuve, T. Jiang, T. Wu, A. Lau, H. A. Toppin, and D. D. Zhang. Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism. Proc. Natl. Acad. Sci. U.S.A. 108:1433-1438, 2011.
33. Scherz-Shouval, R., E. Shvets, E. Fass, H. Shorer, L. Gil, and Z. Elazar. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J. 26:1749-1760, 2007.
34. Shelton, P., and A. K. Jaiswal. The transcription factor NF-E2-related factor 2 (Nrf2): a protooncogene? FASEB J. 27:414-423, 2013.
35. Shibata, T., T. Ohta, K. I. Tong, A. Kokubu, R. Odogawa, K. Tsuta, H. Asamura, M. Yamamoto, and S. Hirohashi. Cancer related mutations in Nrf2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc. Natl. Acad. Sci. U.S.A. 105:13568-13573, 2008.
36. Sun, Z., T. Wu, F. Zhao, A. Lau, C. M. Birch, and D. D. Zhang. KPNA6 (importin α7)-mediated nuclear import of Keap1 represses the Nrf2-dependent antioxidant response. Mol. Cell. Biol. 31:1800-1811, 2011.
37. Taguchi, K., H. Motohashi, and M. Yamamoto. Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 16:123-140, 2011.
38. Velichkova, M., and T. Hasson. Keap1 regulates the oxidation-sensitive shuttling of Nrf2 into and out of the nucleus via a Crm1-dependent nuclear export mechanism. Mol. Cell. Biol. 25:4501-4513, 2005.
39. Wakabayashi, N., S. L. Slocum, J. J. Skoko, S. Shin, and T. W. Kensler. When Nrf2 talks, who's listening? Antioxid. Redox Signal. 13:1649-1663, 2010.
40. Wang, X. J., Z. Sun, N. F. Villeneuve, S. Zhang, F. Zhao, Y. Li, W. Chen, X. Yi, W. Zheng, G. T. Wondrak, P. K. Wong, and D. D. Zhang. Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis 29:1235-1243, 2008.
41. Watai, Y., A. Kobayashi, H. Nagase, M. Mizukami, J. McEvoy, J. D. Singer, K. Itoh, and M. Yamamoto. Subcellular localization and cytoplasmic complex status of endogenous Keap1. Genes Cells 12:1163-1178, 2007.
42. Wesierska-Gadek, J., A. Borza, E. Walzi, V. Krystof, M. Maurer, O. Komina, and S. Wandl. Outcome of treatment of human HeLa cervical cancer cells with roscovitine strongly depends on the dosage and cell cycle status prior to the treatment. J. Cell. Biochem. 106:937-955, 2009.
43. Wu, C. C., C. W. Hsu, C. D. Chen, C. J. Yu, K. P. Chang, D. I. Tai, H. P. Liu, W. H. Su, Y. S. Chang, and J. S. Yu. Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas. Mol. Cell. Proteomics 9:1100-1117, 2010.
44. Xu, B. J., W. Yan, B. Jovanovic, A. Q. An, N. Cheng, M. E. Aakre, Y. Yi, J. Eng, A. J. Link, and H. L. Moses. Quantitative analysis of the secretome of TGF-β signaling-deficient mammary fibroblasts. Proteomics 10:2458-2470, 2010.
45. Yu, R., W. Lei, S. Mandlekar, M. J. Weber, C. J. Der, J. Wu, and A. N. Kong. Role of a mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals. J. Biol. Chem. 274:27545-27552, 1999.
46. Yuan, X., C. Xu, Z. Pan, Y. S. Keum, J. H. Kim, G. Shen, S. Yu, K. T. Oo, J. Ma, and A. N. Kong. Butylated hydroxyanisole regulates ARE-mediated gene expression via Nrf2 coupled with ERK and JNK signaling pathway in HepG2 cells. Mol. Carcinog. 45:841-850, 2006.
47. Ziady, A. G., A. Sokolow, S. Shank, D. Corey, R. Myers, S. Plafker, and T. J. Kelley. Interaction with CREB binding protein modulates the activities of Nrf2 and NF-κb in cystic fibrosis airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 302:L1221-L1231, 2012.